title: Platelet adhesion studies on nanostructured poly(lactic-co-glycolic-acid)-carbon nanotube composite.
abstract: Design of blood-compatible surfaces is required to minimize platelet-surface interactions and increase the thromboresistance of foreign surfaces. Poly(lactic-co-glycolic-acid)-carbon nanotube (PLGA-CNT) composite is studied as a building material to fabricate artificial blood prostheses. This nanocomposite-based biomaterial is prepared by an electrostatic Layer-by-Layer (LbL) deposition technique, in which layers of CNTs are adsorbed onto a PLGA film. Before incubation in nonstimulated platelet-rich plasma (PRP) for platelet studies, fibrinogen is immobilized on PLGA-CNT composite. Interactions between the plasma proteins, e.g. fibrinogen and PRP, are investigated on the prepared PLGA-CNT composite. Contact angle measurements on the PLGA-CNT composite displayed a good resistance of platelets adhesion on a hydrophilic surface with an angle of 64.94 degrees as compared to pristine PLGA control with an angle of 93.43 degrees . A significant reduction of adhesion is observed on the PLGA-CNT composite, as well as the absence of platelet activation. On the contrary, both platelet adhesion and activation are observed on control samples. We inferred this suppression in secretion of granule contents in the platelet by the presence of the CNTs that resulted in the absence of platelet activation and its subsequent inhibition in the release of adhesive membrane receptors on the PLGA-CNT composite.
authors.affiliation: School of Materials Science and Engineering, Nanyang Technological University, Singapore.
authors.forename: Li Buay
authors.initials: LB
authors.lastname: Koh
authors.forename: Isabel
authors.initials: I
authors.lastname: Rodriguez
authors.forename: Jijie
authors.initials: J
authors.lastname: Zhou
mesh_terms: D001672:Biocompatible Materials; D006801:Humans; D019344:Lactic Acid / Q000009:adverse effects*; D008422:Materials Testing; D053761:Nanocomposites / Q000009:adverse effects / Q000737:chemistry*; D037742:Nanotubes, Carbon / Q000009:adverse effects*; D015539:Platelet Activation / Q000187:drug effects; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011100:Polyglycolic Acid / Q000009:adverse effects*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer
chemical_list: D001672:Biocompatible Materials; D037742:Nanotubes, Carbon; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid